Company Filing History:

13 out of 136

Zambon Group S.p.a.

Years Active: 1987-1999

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6005005 - Liquid pharmaceutical composition for oral use containing (1999-12-21),

2. 5869102 - Solid pharmaceutical compositions containing (S)-2-(4-isobutylphenyl) (1999-02-09),

3. 5807894 - Syrup containing N-acetyl-cysteine (1998-09-15),

4. 5767161 - Pharmaceutical compositions for topical use containing (1998-06-16),

5. 5693312 - Pharmaceutical composition having analgesic activity (1997-12-02),

6. 5645857 - Pharmaceutical composition having analgesic activity (1997-07-08),

7. 5510385 - Pharmaceutical compositions containing the salts of (1996-04-23),

8. 5510101 - Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and (1996-04-23),

9. 5500226 - Pharmaceutical composition having analgesic activity (1996-03-19),

10. 5488069 - Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and (1996-01-30),

11. 5463117 - Process for the preparation of salts of 2-(4-isobutylphenyl)propionic (1995-10-31),

12. 5459157 - Pharmaceutical composition for ophthalmic use comprising a nonsteroidal (1995-10-17),

13. 5312627 - Transdermal therapeutic system for the administration of drugs having (1994-05-17),

14. 4834966 - Pharmaceutical composition with analgesic activity (1989-05-30),

15. 4689218 - Effervescent composition with analgesic activity (1987-08-25),

Title: Federico Stroppolo: Innovator in Pharmaceutical Solutions

Introduction

Federico Stroppolo is an accomplished inventor based in Pregassona, Switzerland, known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of 15 patents, his innovative work focuses on enhancing drug formulations and delivery systems.

Latest Patents

Among his latest inventions, Stroppolo has developed liquid pharmaceutical compositions for oral use that aim to improve bioavailability and patient compliance. Additionally, he holds patents for solid pharmaceutical compositions containing (S)-2-(4-isobutylphenyl), showcasing his expertise in creating effective therapeutic solutions.

Career Highlights

Stroppolo has made a notable impact at Zambon Group S.p.A. and Zambon S.p.A., where he worked on patenting groundbreaking medicinal formulations. His experience at these esteemed companies has allowed him to leverage his research and development skills effectively, driving innovation in pharmaceutical sciences.

Collaborations

Throughout his career, Stroppolo has collaborated with professionals like Daniele Bonadeo and Annibale Gazzaniga. These partnerships have contributed to his success in developing advanced pharmaceutical solutions that address critical healthcare needs.

Conclusion

Federico Stroppolo's dedication to innovation in the pharmaceutical field is reflected in his extensive patent portfolio and collaborations with notable colleagues. His work continues to influence the development of effective treatments, making significant strides toward improving patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com